MarketCapTrends
ABBV

AbbVie Inc. (ABBV)

NYSE · Healthcare

AbbVie Inc. annual/quarterly shareholder equity history from 2012 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.

  • AbbVie Inc. shareholder equity for the quarter ending December 31, 2025 were -3.27B, a 198.35% decrease year-over-year.
  • AbbVie Inc. shareholder equity for 2025 were -3.27B, a 198.35% decrease from 2024.
  • AbbVie Inc. shareholder equity for 2024 were 3.33B, a 67.91% decrease from 2023.
  • AbbVie Inc. shareholder equity for 2023 were 10.36B, a 39.96% decrease from 2022.
  • AbbVie Inc. shareholder equity for 2022 were 17.25B.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
AbbVie Inc. Annual Shareholder Equity (Millions of US $)
2025$-3,270
2024$3,325
2023$10,360
2022$17,254
2021$15,408
2020$13,076
2019$-8,172
2018$-8,446
2017$5,097
2016$4,636
2015$3,945
2014$1,742
2013$4,492
2012$-350
AbbVie Inc. Quarterly Shareholder Equity (Millions of US $)
2025-12-31$-3,270
2024-12-31$3,325
2023-12-31$10,360
2022-12-31$17,254
2021-12-31$15,408
2020-12-31$13,076
2019-12-31$-8,172
2018-12-31$-8,446
2017-12-31$5,097
2016-12-31$4,636
2015-12-31$3,945
2014-12-31$1,742
2013-12-31$4,492
2012-12-31$-350

AbbVie Inc. Shareholder Equity — FAQ

AbbVie Inc. (ABBV) shareholder equity over the last 15 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see ABBV's shareholder equity history?

The chart and table above show AbbVie Inc.'s shareholder equity by year and by quarter, including the growth rate.